Moderna is trading 4.52% lower at $189.90 amid broader risk-off sentiment linked to higher oil and renewed inflation concerns. - President Trump’s rejection of Iran’s proposal to reopen the Strait of Hormuz pushed oil higher. - The move revived inflation concerns, weighing on stock futures and lifting Treasury yields; major U.S. indices are also down. - No clear new company-specific announcement explaining Moderna’s decline surfaced in available searches; the macro backdrop is the clearest available explanation, not a confirmed company-specific catalyst.